BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options
The launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients. FRANKLIN LAKES, N.J., Oct. 28, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. commercial...
Covered in this story
Call it yourself
No calls on $BDX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Becton Dickinson →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.